February 15, 2018 / 1:50 PM / 9 days ago

BRIEF-Parker-Hannifin's Indego Exoskeleton Receives FDA Clearance For Stroke Treatment

Feb 15 (Reuters) - Parker-Hannifin Corp:

* INDEGO® EXOSKELETON RECEIVES U.S. REGULATORY CLEARANCE FOR STROKE TREATMENT

* PARKER-HANNIFIN - ‍FDA GIVEN ADDITIONAL CLEARANCE TO MARKET & SELL INDEGO EXOSKELETON FOR USE IN TREATMENT OF INDIVIDUALS WITH HEMIPLEGIA DUE TO STROKE​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below